Searched for
RANJIT SHAHANI
India Inc CEOs walk the talk on healthTo help its people 'Walk the Talk', Max Bupa introduced a wellness programme called 'Step for Health' last year.
Exchanging notes about parenthood! Radha Kapoor and Siddharth Shahani will be happy parents soonRadha Kapoor, daughter of Yes Bank founder Rana Kapoor and Siddharth Shahani, scion of Novartis India are over the moon.
The truth behind my beautiful saris is my husband: Indu Shahani, principal of HR CollegeIndu's husband Ranjit Shahani, the MD of Novartis India, chooses the saris for his wife. Indu says buying saris has been his passion.
Top knot: Style files from biz worldWhile big plans to make India the next start-up hub were discussed at the ET Global Business Summit, we noticed some trends in power dressi...
India needs predictable IPR regime: NovartisThe Department of Industrial Policy and Promotion is expected to soon take the draft IPR policy to the Cabinet for approval.
Novartis gets USFDA nod for heart failure drugThe Swiss drug major said the USFDA's decision was based on results of a study on 8,442 patients, including 637 from India.
Narendra Kumar showcases his fashion coutureDesigner Narendra Kumar showcased his fashion couture with the models alighting from an aeroplane at this party to launch the new calendar ...
Novartis India vice-chairman & managing director, Ranjit Shahani says company now focuses on new products, business growthNovartis India has over the past year launched three successful patented drugs and over 12 generic drugs that have helped it expand its pre...
Domestic pharma companies may gain as MNCs set to swallow bitter marketing pillA cautious strategy adopted by MNCs in promoting medicines could affect MNCs, including GSK, and impact their growth prospects in the India...
Individual cases to dictate MNC drug cos’ approach to patentsRoche’s decision to give up India patent for Herceptin unlikely to set a precedent, says MNC drug companies’ body.
Novartis sacks 18 for fabricating sales dataThe Indian subsidiary of Swiss drug maker Novartis has dismissed some 18 middle-level sales executives for fabricating and inflating the sa...
Novartis wants Indian patent system to improve, compares with ChinaWe will continue with our investments in India, though cautiously. We hope that the ecosystem for intellectual property improves, Ranjit Sh...
- FDI cap in pharma will hurt global investor confidence: OPPI
Imposing restrictions on FDI in the pharmaceutical sector, in the wake of MNCs acquiring domestic firms would hurt overseas investment flow...
- Restricting FDI in pharma will be retrograde step: OPPI
The Organisation of Pharmaceutical Producers of India (OPPI) today said any move to contain FDI in the pharma sector will be a "retrograde ...
- Novartis upbeat on rural sales programme, to double its reach
Novartis' Indian arm is very upbeat about its rural sales initiative -- Arogya Parviar -- and plans to double its reach in the country over...
- Novartis to fully integrate Alcon by end-2010
Swiss drug maker, Novartis, is looking at fully integrating US-based eye-care group Alcon from Nestle by the end of this year, a top compan...
- Indian drug firms need to tighten belts to meet FDA norms
Indian generic drug makers could face more actions from the US FDA unless they maintain high quality requirements of the regulator, which h...
- Novartis launches programme to cover rural areas
Novartis India on Wednesday said it has launched Arogya Parivar, a programme, to address the health needs of rural areas, which would give ...
- Novartis to make a presentation to PMO on rural pharma
Novartis will make a presentation to the PMO on selling over-the-counter medicines from post offices in rural areas to increase the industr...
- Novartis to make a presentation to PMO on rural pharma
Global pharma major Novartis will make a presentation to the Prime Minister's Office on selling over-the-counter medicines from post office...